Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM

BACKGROUND: MiR-106a is frequently down-regulated in various types of human cancer. However the underlying mechanism of miR-106a involved in glioma remains elusive. METHODS: The association of miR-106a with glioma grade and patient survival was analyzed. The biological function and target of miR-106...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Dong-Wei, Lu, Qiong, Wang, Lai-Xing, Zhao, Wen-Yuan, Cao, Yi-Qun, Li, Ya-Nan, Han, Guo-Sheng, Liu, Jian-Min, Yue, Zhi-Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853007/
https://www.ncbi.nlm.nih.gov/pubmed/24124917
http://dx.doi.org/10.1186/1471-2407-13-478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853007/
https://www.ncbi.nlm.nih.gov/pubmed/24124917
http://dx.doi.org/10.1186/1471-2407-13-478

Ejemplares similares